by Stephane Cailmail | 6 Oct 2021 | Actualités générales, General news, Publications, Research
What signals do cancer cells send to prevent these therapies from working? A targeted therapy is a therapy that prevents a specifically active signal in tumour cells. Our team is interested in inhibitors of PI3Ks, innovative targeted therapies for solid and liquid...
by Stephane Cailmail | 1 Apr 2021 | Actualités générales, Publications, Research
Researchers from LAAS-CNRS, in collaboration with the Toulouse Cancer Research Centre, have shown how μLAS microfluidic chip technology can concentrate and measure microRNAs, cancer biomarkers, in less than a minute. MicroRNAs (miRs) are short fragments of RNA that...
by Stephane Cailmail | 23 Mar 2021 | Actualités générales, Publications, Research
PI3Ks are important molecules, that, by adding a tag on a lipid, induce messages (also called signals) in the cells. They are hence key regulators of cell signalling. In the animals of higher order, such as Humans, PI3Ks come in different flavours. In particular, the...
by Stephane Cailmail | 27 Nov 2020 | Actualités générales
This year, the German Cancer Society (AEK) is presenting “the 5th AEK Autumn School” on the theme of “replicative stress and cancer”. This Autumn School aims to promote exchanges between young scientists and experienced researchers in the...
by Stephane Cailmail | 25 Nov 2020 | Actualités générales, Research
An unmissable event for researchers and clinicians from the Greater South-West, the Annual Days are a place for exchange, providing an opportunity to take stock of the Cancéropôle’s programmes and strategic areas of focus. These meetings encourage closer links...
by Stephane Cailmail | 13 Nov 2020 | Actualités générales
Nearly €10 million has just been allocated via ERC (European Research Council) Synergy funding to 4 international teams for a period of 6 years. The “ATTACK” project of Salvatore Valitutti, team leader at the CRCT, is focused on the analysis of the...
